Anzeige
Mehr »
Login
Samstag, 02.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
200.000 Unzen pro Jahr: Die Goldaktie, die kurz davor steht, Geschichte zu schreiben
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 889120 | ISIN: US0352551081 | Ticker-Symbol: AKP
Frankfurt
01.11.24
08:00 Uhr
15,700 Euro
-6,900
-30,53 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
ANIKA THERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
ANIKA THERAPEUTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
14,60015,80001.11.

Aktuelle News zur ANIKA THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrAnika Therapeutics Inc reports results for the quarter ended in September 30 - Earnings Summary2
DoAnika Therapeutics veräußert Arthrosurface und plant Verkauf von Parcus3
DoAnika Therapeutics divests Arthrosurface, eyes Parcus sale2
DoAnika Therapeutics-Aktie erreicht 52-Wochen-Tief bei 18,67 US-Dollar-
DoAnika Therapeutics Non-GAAP EPS of -$0.25, revenue of $38.8M5
DoAnika Therapeutics, Inc. - 8-K, Current Report1
DoAnika Therapeutics Inc.: Anika Reports Third Quarter 2024 Financial Results74Updating 2024 fiscal year guidance to reflect announced changes to business strategy, including the sale of Arthrosurface and planned divestiture of Parcus Medical, and U.S. OA Pain Management headwinds...
► Artikel lesen
DoAnika Therapeutics Inc.: Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus Medical57BEDFORD, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced the divestiture...
► Artikel lesen
MiWhat's Next: Anika Therapeutics' Earnings Preview2
04.10.Anika Therapeutics Inc.: Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)120BEDFORD, Mass., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on October 1...
► Artikel lesen
09.09.Anika Therapeutics Inc.: Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)73BEDFORD, Mass., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on September...
► Artikel lesen
15.08.Anika Therapeutics Inc.: Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)79BEDFORD, Mass., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on August 1,...
► Artikel lesen
09.08.Anika Therapeutics, Inc. (ANIK): Are Hedge Funds Bullish on This Caligan Partners-Approved Stock?1
08.08.Anika Therapeutics Inc reports results for the quarter ended in June - Earnings Summary1
08.08.Anika Therapeutics, Inc. - 10-Q, Quarterly Report1
08.08.Anika Therapeutics Non-GAAP EPS of $0.17 misses by $0.03, revenue of $41.9M beats by $1.13M1
08.08.Anika Therapeutics Inc.: Anika Reports Second Quarter 2024 Financial Results103Expanded Regenerative Solutions portfolio with full market release of the Integrity Implant System, a hyaluronic acid (HA)-based scaffold for rotator cuff and other tendon repairs, generating significant...
► Artikel lesen
05.08.Anika Therapeutics Inc.: Anika to Participate in the Sidoti Virtual Investor Conference1
25.07.Anika Therapeutics Inc.: Anika to Issue Second Quarter 2024 Financial Results on Thursday, August 8, 20241
16.07.Anika Therapeutics Inc.: Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)64BEDFORD, Mass., July 16, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on July 1, 2024...
► Artikel lesen
Seite:  Weiter >>
40 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1